Continued rigorous research on real-world psychedelic use is important to inform clinical care, advise public health strategies, and make evidence-based policy decisions.

Psychedelic treatments for mental health and substance use disorders are still in an early phase of development and many gaps in the evidence exist, including whether treatment effects vary by …

Psychedelics are a class of psychoactive compounds that, when ingested by humans, temporarily alter our brain chemistry and afect our perception, mood, and cognitive processes in characteristic ways. …

Use of psychedelics can pose short-term and long-term risks, including hallucinogen use disorder and other mental health related risks. The use of psychedelic and empathogenic agents for psychiatric …

“I entered the experience believing that my experience is the literal real external world. The experience contained me living out my worst fears, the deepest possible shame. Other experiences so bizarre …

The therapeutic use of psychedelic substances such as LSD and psilocybin has been researched by psychol-ogists and psychiatrists for a range of psychiatric disorders, including substance use …

To help make sense of where the evidence base for these therapies stands in 2022, the writing team has undertaken a rapid but comprehensive review of the current academic literature on psychedelic …